SCHEMBL3079689

SCHEMBL3079689

Fc1ccc(-c2coc3nccn23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 6/20 0.44
POLB P06746 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 1/20 0.35
EGLN2 Q96KS0 1/20 0.34
MAPK14 Q16539 1/20 0.34
PTGS1 P23219 2/20 0.34
PTGS2 P35354 2/20 0.34
CSNK1E P49674 2/20 0.34
KDM5A P29375 1/20 0.34
KDM2B Q8NHM5 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
ADORA2A P29274 1/20 0.34
CCNT1 O60563 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14844916 0.67 CYP17A1 (0.44) FLT3POLBALDH1A1HPGDMEN1
SCHEMBL3085669 0.67 IDO1 (0.71) FLT3POLBALDH1A1HPGDKDM4E
SCHEMBL5412317 0.62 FLT3 (0.46) FLT3ALDH1A1HPGDMEN1KMT2A
SCHEMBL3702960 0.60 GRIA1 (0.38) POLBALDH1A1HPGDMEN1KMT2A
SCHEMBL4204691 0.60 ALDH1A1 (0.44) FLT3POLBALDH1A1HPGDMEN1
SCHEMBL14844909 0.59 CYP17A1 (0.42) FLT3POLBALDH1A1MEN1KMT2A
SCHEMBL27741873 0.58 MEN1 (0.42) FLT3POLBALDH1A1HPGDMEN1
SCHEMBL22777380 0.58 ADORA2A (0.47) MAPK14PTGS2CSNK1EADORA2ACCNT1
SCHEMBL3462133 0.58 HDAC4 (0.46) POLBALDH1A1HPGDMEN1KMT2A
SCHEMBL15473570 0.58 CYP17A1 (0.46) ALDH1A1MEN1KMT2AKDM4EMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790741-B2 Imidazothiazoles and imidazoxazoles ABBOTT LABORATORIES (US) 2010-09-07 US disclosed
US-20080161341-A1 Novel imidazothiazoles and imidazoxazoles ABBVIE INC. 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161341-A1 Novel imidazothiazoles and imidazoxazoles MAP3K1, MAP3K19, MAP3K5 FLT3 273/4885POLB 2315/4885ALDH1A1 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.